And the Four Psychological Conditions We Now Know Are Lifelong Disorders
By John Preston - Ultimately, while psychiatric drugs do save lives, the fact remains that integrative treatment (psychotherapy, lifestyle changes, exercise, and sometimes medications) works best. It behooves us to give our clients the best we have to offer, which involves much more than just offering pills to temporarily relieve symptoms.
Oral Histories of Psychotherapy 1978-2017
A group of innovators and leaders look back over different realms of therapeutic practice and offer their view of the eureka moments, the mistakes and misdirections, and the inevitable trial-and-error processes that have shaped the evolution of different specialty areas within the field.
- Trauma: Retreats and Advances BESSEL VAN DER KOLK
- Couples: In Search of a Safe Haven JOHN GOTTMAN
- Systems Therapy: The Art of Creating Uncertainty SALVADOR MINUCHIN
- Family Violence: Out of the Shadows MARY JO BARRETT
- Psychopharmacology: The Jury Is Still Out JOHN PRESTON
- Race Matters: How Far Have We Come? KENNETH HARDY
- Neuroscience and Therapy: The Craft of Rewiring the Brain DANIEL SIEGEL
How to Mobilize the Client’s Support System
It’s always cause for celebration when depressed clients nears the finish line of treatment, feeling energized, empowered, and more content with their life. But it’s one thing to get people back on their feet from a depressive episode; it’s another to prevent recurrences down the road.
Helping Clients Recognize their Treatment Options
When it comes to treating depression, neuropsychologist John Preston, author of Clinical Psychopharmacology Made Ridiculously Simple, says that psychoactive medication is only one alternative and often not the most effective. In addition to his integrative approach—which includes exercise, combating social withdrawal, family involvement, and possibly meds—he’s always on the lookout for toxic relationship issues in the client’s life.
Have They Lived up to Their Promise?
After wading through the controversies and contradictions in the research literature on SSRIs, a critic of Big Pharma explains why he thinks these drugs may have gotten a bad rap.
It’s More Complicated Than That: Probing the complexities of the antidepressants debate
The recent spate of negative research findings and unfavorable media coverage of antidepressant drugs have obscured some important clinical issues.